| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.35 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.31 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.066 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.044 | 0.4 |